Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 4/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | BRAF | P15056 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21563712 | 0.96 | RXFP1 (0.39) | RXFP1PPARGNR1H4MAPTPPARA | |
| SCHEMBL21563474 | 0.92 | RXFP1 (0.36) | RXFP1PPARGNR1H4PPARA | |
| SCHEMBL23716792 | 0.87 | RXFP1 (0.39) | RXFP1PPARGNR1H4MAPTPPARA | |
| SCHEMBL12548713 | 0.82 | RXFP1 (0.38) | GAARXFP1PPARGNR1H4MAPT | |
| SCHEMBL23716448 | 0.81 | GPBAR1 (0.36) | — | |
| SCHEMBL21563641 | 0.80 | NR1H3 (0.34) | — | |
| SCHEMBL29409939 | 0.80 | GAA (0.41) | GAARXFP1PPARGNR1H4MAPT | |
| SCHEMBL31175823 | 0.80 | HTR1F (0.39) | GAARXFP1PPARGNR1H4MAPT | |
| SCHEMBL21563472 | 0.79 | RXFP1 (0.46) | GAARXFP1PPARGNR1H4POLB | |
| SCHEMBL31175832 | 0.79 | RXFP1 (0.46) | GAARXFP1PPARGNR1H4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238126-A1 | Benzamide Compound and Use Thereof | METISA BIOTECHNOLOGY CO.,LTD. (CN) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238126-A1 | Benzamide Compound and Use Thereof | TMBIM6, BCHE, DDT | GAA 150/4885RXFP1 3251/4885PPARG 927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.